These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1743595)
1. Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia. Locatelli F; Pedrazzoli P; Zecca M; Maccario R; Giorgiani G; Prete L; Nespoli L; Severi F Haematologica; 1991; 76(3):238-9. PubMed ID: 1743595 [TBL] [Abstract][Full Text] [Related]
2. Correction of neutropenia with rHuG-CSF after loss of response to rHuGM-CSF following autologous bone marrow transplant. Boulad F; Gillio A; Small TN; Bonilla MA; Philips P; Ruggiero M; Emanuel D; Ghavimi F; Kernan NA Bone Marrow Transplant; 1994 May; 13(5):661-3. PubMed ID: 7519939 [TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with antibiotics in the treatment of febrile neutropenia in children. Riikonen P Stem Cells; 1995 May; 13(3):201-5. PubMed ID: 7613488 [TBL] [Abstract][Full Text] [Related]
4. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT. De Witte T; Gratwohl A; Van der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE Bone Marrow Transplant; 1991; 7 Suppl 2():83. PubMed ID: 1908729 [No Abstract] [Full Text] [Related]
5. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome. Hazar V; Ongun H; Yeşilipek MA; Yeğin O Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686 [TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation. Geissler K; Harrington M; Srivastava C; Leemhuis T; Tricot G; Broxmeyer HE J Immunol; 1989 Jul; 143(1):140-6. PubMed ID: 2471733 [TBL] [Abstract][Full Text] [Related]
7. Human granulocyte colony-stimulating factor (rHuG-CSF) for treatment of neutropenia in Shwachman syndrome. Ventura A; Dragovich D; Luxardo P; Zanazzo G Haematologica; 1995; 80(3):227-9. PubMed ID: 7545636 [TBL] [Abstract][Full Text] [Related]
8. [Rapid recovery after treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF) for neutropenia caused by indomethacin]. Costa RM; Leite J Sangre (Barc); 1993 Dec; 38(6):502-3. PubMed ID: 8171389 [No Abstract] [Full Text] [Related]
9. Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Linch DC; Scarffe H; Proctor S; Chopra R; Taylor PR; Morgenstern G; Cunningham D; Burnett AK; Cawley JC; Franklin IM Bone Marrow Transplant; 1993 Apr; 11(4):307-11. PubMed ID: 7683552 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors. Cetingül N; Kütükçüler N; Kantar M; Kavakli K; Nişli G; Cağlayan S; Oztop S Turk J Pediatr; 1997; 39(4):473-81. PubMed ID: 9433149 [TBL] [Abstract][Full Text] [Related]
11. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor. Sieff C; Guinan E Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316 [TBL] [Abstract][Full Text] [Related]
12. Mean myeloperoxidase index in lymphoma transplants receiving recombinant granulocyte-macrophage colony stimulating factor. Tsakona CP; Khwaja A; Goldstone AH Bone Marrow Transplant; 1993 Apr; 11(4):345-6. PubMed ID: 8387371 [No Abstract] [Full Text] [Related]
13. [rhG-CSF treatment in cyclic neutropenia. Continuous versus intermittent rhG-CSF treatment in cyclic neutropenia]. Nielsen H; Hansen PB Ugeskr Laeger; 1994 Jan; 156(3):324-5. PubMed ID: 8296427 [TBL] [Abstract][Full Text] [Related]
14. Abnormal responses of myeloid progenitor cells to granulocyte-macrophage colony-stimulating factor in human cyclic neutropenia. Wright DG; LaRussa VF; Salvado AJ; Knight RD J Clin Invest; 1989 Apr; 83(4):1414-8. PubMed ID: 2649515 [TBL] [Abstract][Full Text] [Related]
15. Future strategy for cancer treatment using recombinant human granulocyte colony stimulating factor. Diehl V Eur J Cancer; 1994; 30A Suppl 3():S44-7. PubMed ID: 7535072 [TBL] [Abstract][Full Text] [Related]
16. [Cyclic neutropenia and treatment with granulocyte colony-stimulating factor (G-CSF)]. Anninga JK; Weening RS Ned Tijdschr Geneeskd; 1995 Feb; 139(8):394-7. PubMed ID: 7885503 [TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients. Page AV; Liles WC Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545 [TBL] [Abstract][Full Text] [Related]
18. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF; Chan HO Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284 [TBL] [Abstract][Full Text] [Related]
19. Neutropenic fever in patients after high-dose chemotherapy followed by autologous haematopoietic progenitor cell transplantation and human recombinant granulocyte-macrophage colony stimulating factor. Glück S; Gagnon A Bone Marrow Transplant; 1994 Dec; 14(6):989-90. PubMed ID: 7711678 [TBL] [Abstract][Full Text] [Related]